Despite TRAIL-R1/2 – expression, most pancreatic cancer cells show resistance to TRAIL-induced apoptosis [20–23] mediated by a high activation level of NF-kappaB [24] which enhances the expression of inhibitors of apoptosis like XIAP and FLIP [20–23]. Here, TNFSF10 is linked to pancreatic neoplasm.